ClinicalTrials.gg

Verona Pharma plc clinical trials

Acquired by Merck & Co., Inc, Oct 7, 2025 · source ↗

The registry lists 19 studies whose lead sponsor is Verona Pharma plc. 1 is recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 3, 2026.

Before and after it joined Merck & Co., Inc

First submitted before Verona Pharma plc became part of Merck & Co., Inc
19
First submitted after Verona Pharma plc became part of Merck & Co., Inc
0
Unclear, or no submission date
0

By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.

What it is testing

The drugs Verona Pharma plc’s studies test, most studies first; none is open now — 4 drugs with a page of their own. Each count opens the studies in search.

Studies, none open

Coming up

2 of Verona Pharma plc’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

All 19 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now15%
  • Under way, not recruiting15%
  • Completed1789%

Phase

  • Phase 215
  • Phase 33
  • Phase 11

Where

  • United States12
  • United Kingdom9
  • Bulgaria3
  • Poland3
  • Hungary2
  • Romania2

Over the years

  1. 14
  2. 15
  3. 16
  4. 317
  5. 18
  6. 19
  7. 20
  8. 21
  9. 22
  10. 23
  11. 24
  12. 25
  13. 026

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Verona Pharma plc13 studies
  • Verona Pharma, Inc., a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA5 studies
  • Verona Pharma Inc1 study

Something wrong with this grouping? Tell us on the Merck & Co., Inc page.

Studies

Recruiting first, then most recently updated. Showing 19 of 19. All Merck & Co., Inc studies →